Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co. KGaA

Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ) has issued an update. Foremost Clean Energy Ltd. has filed an early warning report after ...

Foremost Clean Energy Stake in Rio Grande Falls Below Early Warning Threshold

Bernstein analyst maintained a Hold rating on Fresenius Medical Care today and set a price target of $25.80. In addition to Bernstein, Fresenius Me...

Fresenius Medical Care (FMS) Receives a Hold from Bernstein

In a report released today, Hassan Al-Wakeel from Barclays maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA, with a price target of...

Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

In a report released today, Richard Felton from Goldman Sachs maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA, with a price target...

Goldman Sachs Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)

Fresenius Medical Care (($FMS)) has held its Q2 earnings call. Read on for the main highlights of the call. Fresenius Medical Care’s latest earning...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FMS	$22.47	-0.79%	648.59K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FMS	$22.47	-0.8%	648.59K
3
4
5
6

FMS

Get Fresenius Medical Care AG & Co. KGaA Data in Excel

Get Fresenius Medical Care AG & Co. KGaA Data in Excel